NCT02921061 2020-03-17Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDSFred Hutchinson Cancer CenterPhase 1/2 Completed28 enrolled 13 charts
NCT00002980 2013-02-15Decitabine in Treating Patients With Melanoma or Other Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed